Warm congratulations - Risconce Medical

2021-07-16

微信图片_20220531141719.jpg

      On July 7, 2021, the "intracranial thrombectomy stent" of Hunan Risconce Medical Technology Development Co., Ltd. was approved to be listed by CMDE, with Registration Certificate No: National Device Registration Approval No. 20213030506.

      Acute ischemic stroke has the characteristics of acute morbidity, high mortality and high disability rate, resulting in high professional requirements and difficult implementation of the clinical trial of "mechanical thrombectomy". During the implementation of this project, the links team gave full play to the characteristics of professional medical support, comprehensive on-site work and excellent supervision skills, actively responded to the requirements of the sponsor, coordinated with the sponsor, played a "hub" role, coordinated the sponsor, researchers, related departments, SMO and other experimental parties, and made every effort to promote the implementation of the project. At the conclusion stage, even under the epidemic situation,we overcame all difficulties, and completed the signature and conclusion of 13 centers within 2 months, which is highly recognized by the management of the sponsor. Our value lies in creating value for the sponsor. Links team is very honored to participate in this project.


 LINKS CRO 

       As a CRO company providing clinical trial services. LINKS CRO focus on innovation, high-risk implantation(intervention) medical device, with one-stop clinical trial solutions for the whole process of medical device research and development.The headquarters of LINKS is based in Shanghai, with subsidiary branches in Beijing, Shanghai, Guangzhou, and Shenzhen, in addition to ten regional offices. The current workforce comprises almost 200 employees, with technical personnel making up over 85% and dispersed across almost 30 cities nationwide.   

      Key Services include CRO, SMO, CER, Audit, Post-market research, core laboratory registration both domestically and overseas, innovation declaration, Expert Consultancy, and overseas enterprise agency services.

      Key Indications include Cardiovascular, Neurovascular, Peripheral Vascular, Surgery Robot, Oncology, Ophthalmology, Medical Cosmetology, and other fields such as orthopedics. There are almost 300 projects consultations and services by LINKS each year.  

1656658734777650.gif